Hypercalcemia due to malignancy includes humoral hypercalcemia of malignancy, hypercalcemia from bone metastases, and hematologic malignancies like multiple myeloma, often involving parathyroid hormone-related peptide (PTHrP) [30-32]. Here, PTHLH is linked to hypercalcemia disease.